1642P The role of BRAF/MEKi rechallenge in BRAFV600 mutated melanoma patients: Insights from a EUMelaReg real-world study.
Saved in:
| Title: | 1642P The role of BRAF/MEKi rechallenge in BRAFV600 mutated melanoma patients: Insights from a EUMelaReg real-world study. |
|---|---|
| Authors: | Gavrilova, I.1 (AUTHOR), Weichenthal, M.2 (AUTHOR), Asher, N.3 (AUTHOR), Ulrich, J.4 (AUTHOR), Ellebaek, E.5 (AUTHOR), Kreuter, A.6 (AUTHOR), Popovic, A.7 (AUTHOR), Stojkovski, I.8 (AUTHOR), Levari, S.9 (AUTHOR), Özdemir, B.10 (AUTHOR), García Castaño, A.11 (AUTHOR), Haanen, J.B.A.G.12 (AUTHOR), Svane, I.M.5 (AUTHOR), Mohr, P.13 (AUTHOR), Ascierto, P.A.14 (AUTHOR), Rutkowski, P.15 (AUTHOR), Gogas, H.16 (AUTHOR), Mangana, J.17 (AUTHOR), Bastholt, L.18 (AUTHOR), Schadendorf, D.19 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS974-S974. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
